MedTech Forum 2023

Join Panels

Taking the ‘Risk’ out of ‘Risk Sharing Agreements’: Leveraging RWE to Connect Regulatory, Innovative Funding Models, and Product Adoption

May 31, 12:00 – 12:50 

Innovative funding models and risk sharing agreements in MedTech have been identified as a key enabler for Medical Technology introduction post CE mark. However conventional Regulatory evidence generation is not fit-for purpose for risk sharing agreements and holistic reimbursement. There is often a disconnect of ‘value’ at product introduction through to full-scale product adoption. This session will provide a concrete roadmap to link evidence generation for MedTech across the product life-cycle: from regulatory approval, to reimbursement and adoption. Technologies focused on will include Robotic Surgery, Advanced Diagnostics and high risk implantable devices. 

Moderator: 

• Richard CHARTER (Vice President MedTech Market Access – Europe & Asia Pacific, Alira Health) 

Speakers: 

• Frederico Calado (Global Real-World Solutions, Alira Health) 
• Rachel Busca (Director, HTA and Real-World Evidence EMEACLA, Edwards Lifesciences) 
• Rossana Alessandrello (Value-based Procurement Director, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS))

The critical role of Procurement in healthcare to unlock Value Based Health Care – transforming public procurement from a transactional – into a value-based approach

June 1, 12:10 – 13:00 

European healthcare systems face significant challenges: how to match the increased demand for healthcare services with an increased lack of qualified staff and to improve patient outcomes while managing the total cost of care delivery. Although medical technologies may not be able to solve all of these challenges, they can certainly be part of the solution. Because of an overall traditional execution of the public procurement and tender process based on volume and price, too many of these technologies still need to be implemented, and the adoption of innovative medtech to be promoted. Needing a new procurement paradigm, MedTech Europe, together with BCG and EHPPA (European Health Public Procurement Association), engaged on a journey to move from volume-based procurement towards value-based procurement. During the session, the speakers will elaborate on how (public) procurement can unlock sustainable value-based health care systems across Europe. 

Moderator: 

•  Richard CHARTER (Vice President MedTech Market Access – Europe & Asia Pacific, Alira Health) 

Speakers: 

• Praful MEHTA (CEO, Vamstar) 

• Andrea RAPPAGLIOSI (Senior Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM, Edwards LifeSciences)